학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 18건 | 목록
1~20
Academic Journal
Pulkka, O-P; Gebreyohannes, YK; Wozniak, A; Mpindi, J-P; Tynninen, O; Icay, K; Cervera, A; Keskitalo, S; Murumägi, A; Kulesskiy, E
CLINICAL CANCER RESEARCH. 25(5):1676-1687
Academic Journal
Shishay AS; Department of Public Health, College of Health Science, Adigrat University, Adigrat, Ethiopia.; Gebrezgiabher BB; Department of Epidemiology and Biostatistics, School of Public Health, College of Health Science, Aksum University, Aksum, Ethiopia.; Gebreyohannes YK; Department of Epidemiology and Biostatistics, School of Public Health, College of Health Science, Aksum University, Aksum, Ethiopia.; Negash BM; School of Medicine, College of Health Science, Aksum University, Aksum, Ethiopia.; Tewele BG; Araya Kahsu College of Health Science, Aksum, Ethiopia.; Berhe ES; Department of Public Health, College of Health Science, Adigrat University, Adigrat, Ethiopia.; Kidane MM; Department of Public Health, College of Health Science, Adigrat University, Adigrat, Ethiopia.; Tekea TM; Department of Public Health, College of Health Science, Adigrat University, Adigrat, Ethiopia.; Gebru TK; Department of Public Health, College of Health Science, Adigrat University, Adigrat, Ethiopia.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Arefayne AK; Department of Biostatistics, School of Public Health, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia.; Meles HG; Department of Biostatistics, School of Public Health, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia.; Senbete GH; Department of Biostatistics, School of Public Health, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia.; Gebrelibanos KB; Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Aksum University, Aksum, Tigray, Ethiopia.; Gebrekorkos LM; Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Aksum University, Aksum, Tigray, Ethiopia.; Gebreyohannes YK; Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Aksum University, Aksum, Tigray, Ethiopia.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Cornillie J; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. jasmien.cornillie@uzleuven.be.; Wozniak A; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.; Li H; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.; Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.; Wellens J; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.; Hompes D; Department of Surgical Oncology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Debiec-Rychter M; Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Sciot R; Department of Pathology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Schöffski P; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Academic Journal
Cornillie J; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Leuven, Belgium. jasmien.cornillie@uzleuven.be.; Wozniak A; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Van Renterghem B; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Van Winkel N; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Wellens J; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Debiec-Rychter M; Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Sciot R; Department of Pathology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Hompes D; Department of Surgical Oncology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Schöffski P; Laboratory of Experimental Oncology, Department of Oncology and Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven and University Hospitals Leuven, Leuven, Belgium.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Academic Journal
Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49 Post 815, 3000, Leuven, Belgium.; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Burton EA; Plexxikon Inc., Berkeley, CA, USA.; Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49 Post 815, 3000, Leuven, Belgium. agnieszka.wozniak@kuleuven.be.; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. agnieszka.wozniak@kuleuven.be.; Matusow B; Plexxikon Inc., Berkeley, CA, USA.; Habets G; Plexxikon Inc., Berkeley, CA, USA.; Wellens J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49 Post 815, 3000, Leuven, Belgium.; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Cornillie J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49 Post 815, 3000, Leuven, Belgium.; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.; Lin J; Plexxikon Inc., Berkeley, CA, USA.; Nespi M; Plexxikon Inc., Berkeley, CA, USA.; Wu G; Plexxikon Inc., Berkeley, CA, USA.; Zhang C; Plexxikon Inc., Berkeley, CA, USA.; Bollag G; Plexxikon Inc., Berkeley, CA, USA.; Debiec-Rychter M; Department of Human Genetics, KU Leuven and University Hospitals, Leuven, Belgium.; Sciot R; Department of Pathology, KU Leuven and University Hospitals, Leuven, Belgium.; Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49 Post 815, 3000, Leuven, Belgium.; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med
Academic Journal
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Academic Journal
Evans EK; Blueprint Medicines, Cambridge, MA 02139, USA.; Gardino AK; Blueprint Medicines, Cambridge, MA 02139, USA.; Kim JL; Blueprint Medicines, Cambridge, MA 02139, USA.; Hodous BL; Blueprint Medicines, Cambridge, MA 02139, USA.; Shutes A; Blueprint Medicines, Cambridge, MA 02139, USA.; Davis A; Blueprint Medicines, Cambridge, MA 02139, USA.; Zhu XJ; Blueprint Medicines, Cambridge, MA 02139, USA.; Schmidt-Kittler O; Blueprint Medicines, Cambridge, MA 02139, USA.; Wilson D; Blueprint Medicines, Cambridge, MA 02139, USA.; Wilson K; Blueprint Medicines, Cambridge, MA 02139, USA.; DiPietro L; Blueprint Medicines, Cambridge, MA 02139, USA.; Zhang Y; Blueprint Medicines, Cambridge, MA 02139, USA.; Brooijmans N; Blueprint Medicines, Cambridge, MA 02139, USA.; LaBranche TP; Blueprint Medicines, Cambridge, MA 02139, USA.; Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Belgium 3000.; Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Belgium 3000.; Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Belgium 3000.; Heinrich MC; VA Health Care System and Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA.; DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Miller S; Blueprint Medicines, Cambridge, MA 02139, USA.; Wolf B; Blueprint Medicines, Cambridge, MA 02139, USA.; Kohl N; Blueprint Medicines, Cambridge, MA 02139, USA.; Guzi T; Blueprint Medicines, Cambridge, MA 02139, USA.; Lydon N; Blueprint Medicines, Cambridge, MA 02139, USA.; Boral A; Blueprint Medicines, Cambridge, MA 02139, USA.; Lengauer C; Blueprint Medicines, Cambridge, MA 02139, USA. clengauer@blueprintmedicines.com.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Wang Y; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: yannick.wang@kuleuven.be.; Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.; Wellens J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.; Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.; Guillén MJ; PharmaMar S.A., Madrid, Spain.; Avilés PM; PharmaMar S.A., Madrid, Spain.; Debiec-Rychter M; Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Sciot R; Department of Pathology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE
Academic Journal
Rausch JL; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Ali AA; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Lee DM; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Gebreyohannes YK; Departments of Oncology and General Medical Oncology, University Hospitals Leuven and KU Leuven Cancer Institute, Leuven, Belgium.; Mehalek KR; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Agha A; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Patil SS; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Tolstov Y; Molecular Urooncology, University of Heidelberg School of Medicine, Heidelberg, Germany.; Wellens J; Departments of Oncology and General Medical Oncology, University Hospitals Leuven and KU Leuven Cancer Institute, Leuven, Belgium.; Dhillon HS; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Makielski KR; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Debiec-Rychter M; Department of Human Genetics, University Hospitals Leuven and KU Leuven, Leuven, Belgium.; Schöffski P; Departments of Oncology and General Medical Oncology, University Hospitals Leuven and KU Leuven Cancer Institute, Leuven, Belgium.; Wozniak A; Departments of Oncology and General Medical Oncology, University Hospitals Leuven and KU Leuven Cancer Institute, Leuven, Belgium.; Duensing A; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. aduensin@pitt.edu.; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. aduensin@pitt.edu.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Academic Journal
Cornillie J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Li H; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Wang Y; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Boeckx B; Laboratory for Translational Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium.; Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Wellens J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. jasmien.cornillie@uzleuven.be.; Vanleeuw U; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Hompes D; Department of Surgical Oncology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Stas M; Department of Surgical Oncology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Sinnaeve F; Department of Orthopedic Surgery, University Hospitals Leuven, Leuven, Belgium.; Wafa H; Department of Orthopedic Surgery, University Hospitals Leuven, Leuven, Belgium.; Lambrechts D; Laboratory for Translational Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium.; Debiec-Rychter M; Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Sciot R; Department of Pathology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. agnieszka.wozniak@kuleuven.be.; Zhai ME; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Wellens J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Cornillie J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Vanleeuw U; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Evans E; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Gardino AK; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Lengauer C; Blueprint Medicines Corporation, Cambridge, Massachusetts.; Debiec-Rychter M; Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Sciot R; Department of Pathology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Wozniak A; a Laboratory of Experimental Oncology, Department of Oncology , KU Leuven , Leuven , Belgium.; Gebreyohannes YK; a Laboratory of Experimental Oncology, Department of Oncology , KU Leuven , Leuven , Belgium.; Debiec-Rychter M; b Department of Human Genetics , KU Leuven , Leuven , Belgium.; Schöffski P; a Laboratory of Experimental Oncology, Department of Oncology , KU Leuven , Leuven , Belgium.; c Department of General Medical Oncology , University Hospitals Leuven, Leuven Cancer Institute , Leuven , Belgium.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE
Academic Journal
Cornillie J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Pokreisz P; CoBioRes NV, Leuven, Belgium.; Casazza A; CoBioRes NV, Leuven, Belgium.; Vreys L; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Wellens J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Vanleeuw U; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Debiec-Rychter M; Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Sciot R; Department of Pathology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Hompes D; Department of Surgical Oncology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. patrick.schoffski@uzleuven.be.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Wawrzyniak R; Department of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, Hallera107, 80-416 Gdańsk, Poland.; Woźniak A; Gebreyohannes YK; Dykcik B; Schöffski P; Markuszewski MJ
Publisher: IOP Pub Country of Publication: England NLM ID: 101463871 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-7163 (Electronic) Linking ISSN: 17527155 NLM ISO Abbreviation: J Breath Res Subsets: MEDLINE
Academic Journal
Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Van Looy T; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Wellens J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Vreys L; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Cornillie J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Vanleeuw U; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.; Aftab DT; Exelixis Inc., South San Francisco, California.; Debiec-Rychter M; Department of Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Sciot R; Department of Pathology, KU Leuven and University Hospitals Leuven, Leuven, Belgium.; Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, and Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. agnieszka.wozniak@med.kuleuven.be.
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Academic Journal
Van Looy T; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.; Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.; Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.; Cornillie J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium ; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Wellens J; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.; Li H; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.; Vanleeuw U; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium.; Floris G; Department of Pathology, KU Leuven and University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Debiec-Rychter M; Department of Human Genetics, KU Leuven and University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Sciot R; Department of Pathology, KU Leuven and University Hospitals Leuven, Herestraat 49, Leuven, Belgium.; Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium ; Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Leuven, Herestraat 49, Leuven, Belgium.
Publisher: BioMed Central Country of Publication: England NLM ID: 101577890 Publication Model: eCollection Cited Medium: Print ISSN: 2045-3329 (Print) Linking ISSN: 20453329 NLM ISO Abbreviation: Clin Sarcoma Res Subsets: PubMed not MEDLINE
Academic Journal
Gebresillassie BM; School of Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.; Gebreyohannes EA; School of Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.; Belachew SA; School of Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.; Emiru YK; School of Pharmacy, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Gebreyohannes, YK
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어